The HER2-Enriched (HER2-E) subtype according to PAM50 is defined by higher expression of ERBB2 along with the upregulated expression of tumor proliferation-related genes at the RNA and protein levels in comparison to other cancer types [44,45]. Here, ERBB2 is linked to neoplasm.